Lucinity, a Reykjavik, Iceland-based anti-money laundering (AML) software developer on a mission to Make Money Good, announced that it closed $17 million in Series B investment. The round was led by Keen Venture Partners and joined by Venturing, recent partner Experian, and major existing investors Crowberry Capital, Karma Ventures, and …

Happeo, an Amsterdam, Netherlands-based intranet platform for fast-moving companies, raised $26 million in Series B funding. The round was led by Endeit Capital, Smartfin, and Evli Growth Partners, with participation from earlier investors Inkef, Maki.vc, and Vendep Capital. The investment strengthens Happeo’s position as a leader in solving information chaos …

Oxford Quantum Circuits (OQC), a London, UK-based Europe’s leading quantum computing company, announced that it closed £38 million ($46.45 million) in Series A. The investment is the UK’s largest-ever Series A in quantum computing. The round was co-led by Lansdowne Partners, and The University of Tokyo Edge Capital Partners (UTEC). …

Retail Rocket, a Rijswijk, Netherlands-based all-in-one retention management platform, announced that it raised $24 million in a Series A funding round led by Cyprus-based private equity fund Flintera. In addition to the funding, Retail Rocket also announced that it acquired a b2c marketing automation platform for retail and restaurant businesses …

TaskHuman, a Palo Alto, California-based digital coaching platform, closed a $20 million Series B funding. The round was led by Madrona, with participation from Impact Venture Capital, RingCentral Ventures, Sure Ventures, and USVP, alongside new investors Gaingels, PeopleTech Angels, Propel(x), Underdog Venture Team, and Zoom Ventures, and angel investors include …

CELUS, a German deep tech company that uses AI to streamline circuit board engineering, raised €25 million in Series A funding. The investment round was led by Earlybird Venture Capital, with participation from DI Capital and existing investors Speedinvest and Plug and Play. A host of individuals participated in the …

CardiaTec Biosciences, a Cambridge, MA-based AI drug target discovery company, specializing in cardiovascular disease, raised £1.4 million in pre-seed funding. The financing round was led by Laidlaw Scholars Ventures and APEX Ventures, with participation from Crista Galli Ventures, o2h ventures, and Cambridge Enterprise. The funds will be used for continued …